Gene · 4628
MYH10: myosin heavy chain 10
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. MYH10: myosin heavy chain 10. Genes, record 4628. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/4628
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P35580 | Myosin-10 | 1,976 | 5 | Ensembl, GeneID, HGNC |
Source UniProt
Patents49
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4670794 A2 | 2025-12-31 | 42 | P35580 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 2700 | P35580 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 2286 | P35580 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 4627 | P35580 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 2286 | P35580 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 2700 | P35580 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 4627 | P35580 | Espacenet |
| EP 4463571 A1 | 2024-11-20 | 229 | P35580 | Espacenet |
| JP 2024123008 A | 2024-09-10 | 7208 | P35580 | Espacenet |
| US 12011480 B2 | 2024-06-18 | 42 | P35580 | Espacenet |
1 to 10 of 49
See all 49 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,195
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | MYH10 papers | Newest fiscal year |
|---|---|---|---|
| ZIAHL001786 | Regulation Of Smooth and Nonmuscle Myosin | 11 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 8 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 6 | 2025 |
| R01GM066817 | The Biochemical Basis for the Mechanics of Cytokinesis | 6 | 2025 |
| P30EY010572 | Ophthalmology Core Facility | 5 | 2025 |
| ZIAHL004232 | Expression Studies of Other Unconventional Myosins | 5 | 2025 |
| R01AG011085 | Ubiquitin‐mediated proteolysis and cell cycle control | 4 | 2025 |
| R01DK095811 | Molecular basis of brush border assembly | 4 | 2025 |
| P30DK058404 | Molecular and Cellular Basis for Digestive Diseases | 3 | 2025 |
| P50HD105351 | Boston Children's Hospital/HMS Intellectual and Developmental Disabilities Research Center | 3 | 2025 |
1 to 10 of 1,195Source NIH's project files
See all 1,195 nih grantsPapers1,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive Analysis of Disulfidptosis-Related Genes in Multiple Myeloma: Implications for Prognosis and Immune Microenvironment. | Acta Haematol | 2026 | 42461871 | PubTator, text mining | PubMed |
| Prognostic and immunological implications of a mitophagy-associated gene signature in bladder cancer. | Transl Androl Urol | 2026 | 42436798 | PubTator, text mining | PubMed |
| Case Report: Acral MYH10::ALK fusion superficial mesenchymal neoplasm: first proof of metastatic potential. | Front Oncol | 2026 | 42311268 | PubTator, text mining | PubMed |
| Glycolytic reprogramming and MYH10 K1520 lactylation mediate eutopic endometrial collagen I deposition driven by PKM2-packaged ectopic endometrial extracellular vesicles. | Mol Hum Reprod | 2026 | 42114139 | PubTator, text mining | PubMed |
| ECE1c promotes glioblastoma invasion via the ROCK2-MYH10 axis and interaction with ACTB. | Am J Transl Res | 2026 | 42007117 | PubTator, text mining | PubMed |
| Leader cell myosin 10 controls adhesion dynamics, invasion, and EMT pathway activation. | Cell Commun Signal | 2026 | 41943107 | PubTator, text mining | PubMed |
| Mitochondrial transfer as a therapeutic target for peripheral neuropathy. | Trends Mol Med | 2026 | 41933993 | PubTator, text mining | PubMed |
| Selective vulnerability of cerebral vasculature to NOTCH3 variants in small vessel disease and rescue by phosphodiesterase-5 inhibitor. | Sci Adv | 2026 | 41931622 | PubTator, text mining | PubMed |
| Mobile Powerhouses: Mitochondria Transfer via Tunnelling Nanotubes in Brain Health and Neurodegenerative Diseases. | Eur J Neurosci | 2026 | 41858106 | PubTator, text mining | PubMed |
| MYH9 mutations differentially stabilize non-muscle myosin II filaments and induce distinct cellular aggregation phenotypes. | Cell Mol Life Sci | 2026 | 41760963 | PubTator, text mining | PubMed |
1 to 10 of 1,322
See all 1,322 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/4628
GET https://conductscience.org/api/genes/v1/4628/patents?page=2